Clinical Trial Update: Possible Ameliorating Effect of N- Acetylcysteine (NAC) on Type-II Diabetes Induced Nephropathy [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial exploring N-acetylcysteine (NAC) for ameliorating diabetes-induced nephropathy; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Kidney Disease
• Diabetic Nephropathies
• Type 2 Diabetes Mellitus

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Al-Azhar University | Conditions: Diabetic Kidney Disease, Diabetes Mellitus, Type 2 | Phase 2, Phase 3 | Status: UNKNOWN